You need to login...
If you are not registered...
| Subscribe to Cancer Stat: | |
|
or call us on: +43 (0)1 71 72 8 900 or email: apus@templetonapus.com |
|
Most viewed
- 1. AbbVie Announces Positive Topline Results from Phase 2 LUMINOSITY Trial Evaluating Telisotuzumab-Vedotin (Teliso-V) for Patients with Previously Treated Non-Small Cell Lung Cancer (NSCLC)
- 2. Already-licensed drugs could be trialed to potentially treat secondary brain cancer, new research finds
- 3. Research highlights need for education to combat cancer in Appalachia
- 4. Why men die younger than women
- 5. Case Report: A complete pathologic response in pancreatic cancer with squamous cell differentiation
- 6. Pancreatic Cancer Market revenue to reach USD 36 Billion by 2036, says Research Nester
- 7. Can we crack this cancer's immune response?
- 8. Pancreatic cancer triggers immune response, but disease-fighting T cells may not easily infiltrate PDAC tumors: Study
- 9. SMFG names deputy Nakashima as group CEO after predecessor's death
- 10. Pancreatic cancer: County Antrim man feels 'lucky to be alive'
Last updated at 19:58 GMT
Hot News Makers
Health/Pharma Companies
-
331286.25
-
60061.55
-
33939.36
-
26380.69
-
10529.83
-
10405.40
-
10161.29
-
9817.67
-
9512.81
-
9358.33
Last updated at 19:10 GMT